<VariationArchive VariationID="2422157" VariationName="NC_000023.10:g.(?_152014869)_(155171615_?)del" VariationType="Deletion" Accession="VCV002422157" Version="4" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1942191" VariationID="2422157">
      <GeneList>
        <Gene Symbol="ABCD1" FullName="ATP binding cassette subfamily D member 1" GeneID="215" HGNC_ID="HGNC:61" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153724856" stop="153744755" display_start="153724856" display_stop="153744755" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152990322" stop="153010215" display_start="152990322" display_stop="153010215" Strand="+" />
          </Location>
          <OMIM>300371</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ABCD1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="ARHGAP4" FullName="Rho GTPase activating protein 4" GeneID="393" HGNC_ID="HGNC:674" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153907378" stop="153926264" display_start="153907378" display_stop="153926264" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153172829" stop="153191713" display_start="153172829" display_stop="153191713" Strand="-" />
          </Location>
          <OMIM>300023</OMIM>
        </Gene>
        <Gene Symbol="ATP2B3" FullName="ATPase plasma membrane Ca2+ transporting 3" GeneID="492" HGNC_ID="HGNC:816" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153517642" stop="153582929" display_start="153517642" display_stop="153582929" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152801579" stop="152848386" display_start="152801579" display_stop="152848386" Strand="+" />
          </Location>
          <OMIM>300014</OMIM>
        </Gene>
        <Gene Symbol="ATP6AP1" FullName="ATPase H+ transporting accessory protein 1" GeneID="537" HGNC_ID="HGNC:868" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154428677" stop="154436516" display_start="154428677" display_stop="154436516" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153656977" stop="153664861" display_start="153656977" display_stop="153664861" Strand="+" />
          </Location>
          <OMIM>300197</OMIM>
        </Gene>
        <Gene Symbol="AVPR2" FullName="arginine vasopressin receptor 2" GeneID="554" HGNC_ID="HGNC:897" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153902625" stop="153907166" display_start="153902625" display_stop="153907166" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153167984" stop="153172619" display_start="153167984" display_stop="153172619" Strand="+" />
          </Location>
          <OMIM>300538</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AVPR2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AVPR2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="BCAP31" FullName="B cell receptor associated protein 31" GeneID="10134" HGNC_ID="HGNC:16695" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153700492" stop="153724387" display_start="153700492" display_stop="153724387" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152965946" stop="152990200" display_start="152965946" display_stop="152990200" Strand="-" />
          </Location>
          <OMIM>300398</OMIM>
          <Haploinsufficiency last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BCAP31">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-08-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BCAP31">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="BGN" FullName="biglycan" GeneID="633" HGNC_ID="HGNC:1044" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153494980" stop="153509546" display_start="153494980" display_stop="153509546" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152760346" stop="152775003" display_start="152760346" display_stop="152775003" Strand="+" />
          </Location>
          <OMIM>301870</OMIM>
        </Gene>
        <Gene Symbol="BRCC3" FullName="BRCA1/BRCA2-containing complex subunit 3" GeneID="79184" HGNC_ID="HGNC:24185" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155071508" stop="155123077" display_start="155071508" display_stop="155123077" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154299694" stop="154351348" display_start="154299694" display_stop="154351348" Strand="+" />
          </Location>
          <OMIM>300617</OMIM>
        </Gene>
        <Gene Symbol="CCNQ" FullName="cyclin Q" GeneID="92002" HGNC_ID="HGNC:28434" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153587925" stop="153599139" display_start="153587925" display_stop="153599139" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152853382" stop="152864631" display_start="152853382" display_stop="152864631" Strand="-" />
          </Location>
          <OMIM>300708</OMIM>
          <Haploinsufficiency last_evaluated="2024-06-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CCNQ">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-06-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CCNQ">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="CLIC2" FullName="chloride intracellular channel 2" GeneID="1193" HGNC_ID="HGNC:2063" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155276211" stop="155334614" display_start="155276211" display_stop="155334614" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154505499" stop="154563985" display_start="154505499" display_stop="154563985" Strand="-" />
          </Location>
          <OMIM>300138</OMIM>
        </Gene>
        <Gene Symbol="CMC4" FullName="C-X9-C motif containing 4" GeneID="100272147" HGNC_ID="HGNC:35428" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155061622" stop="155071136" display_start="155061622" display_stop="155071136" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154289896" stop="154299546" display_start="154289896" display_stop="154299546" Strand="-" />
          </Location>
          <OMIM>301088</OMIM>
        </Gene>
        <Gene Symbol="CTAG1A" FullName="cancer/testis antigen 1A" GeneID="246100" HGNC_ID="HGNC:24198" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154585133" stop="154586816" display_start="154585133" display_stop="154586816" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153813417" stop="153815074" display_start="153813417" display_stop="153815074" Strand="+" />
          </Location>
          <OMIM>300657</OMIM>
        </Gene>
        <Gene Symbol="CTAG1B" FullName="cancer/testis antigen 1B" GeneID="1485" HGNC_ID="HGNC:2491" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154617609" stop="154619282" display_start="154617609" display_stop="154619282" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153845864" stop="153847521" display_start="153845864" display_stop="153847521" Strand="-" />
          </Location>
          <OMIM>300156</OMIM>
        </Gene>
        <Gene Symbol="CTAG2" FullName="cancer/testis antigen 2" GeneID="30848" HGNC_ID="HGNC:2492" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154651977" stop="154653579" display_start="154651977" display_stop="154653579" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153880245" stop="153881852" display_start="153880245" display_stop="153881852" Strand="-" />
          </Location>
          <OMIM>300396</OMIM>
        </Gene>
        <Gene Symbol="DKC1" FullName="dyskerin pseudouridine synthase 1" GeneID="1736" HGNC_ID="HGNC:2890" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154762864" stop="154777689" display_start="154762864" display_stop="154777689" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153991030" stop="154005963" display_start="153991030" display_stop="154005963" Strand="+" />
          </Location>
          <OMIM>300126</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="DNASE1L1" FullName="deoxyribonuclease 1 like 1" GeneID="1774" HGNC_ID="HGNC:2957" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154401236" stop="154412101" display_start="154401236" display_stop="154412101" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153629578" stop="153640426" display_start="153629578" display_stop="153640426" Strand="-" />
          </Location>
          <OMIM>300081</OMIM>
        </Gene>
        <Gene Symbol="DUSP9" FullName="dual specificity phosphatase 9" GeneID="1852" HGNC_ID="HGNC:3076" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153642441" stop="153651326" display_start="153642441" display_stop="153651326" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152907896" stop="152916780" display_start="152907896" display_stop="152916780" Strand="+" />
          </Location>
          <OMIM>300134</OMIM>
        </Gene>
        <Gene Symbol="EMD" FullName="emerin" GeneID="2010" HGNC_ID="HGNC:3331" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379295" stop="154381523" display_start="154379295" display_stop="154381523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153607596" stop="153609882" display_start="153607596" display_stop="153609882" Strand="+" />
          </Location>
          <OMIM>300384</OMIM>
        </Gene>
        <Gene Symbol="F8" FullName="coagulation factor VIII" GeneID="2157" HGNC_ID="HGNC:3546" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154835792" stop="155022723" display_start="154835792" display_stop="155022723" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154064062" stop="154250997" display_start="154064062" display_stop="154250997" Strand="-" />
          </Location>
          <OMIM>300841</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=F8">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="F8A1" FullName="coagulation factor VIII associated 1" GeneID="8263" HGNC_ID="HGNC:3547" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154886355" stop="154888061" display_start="154886355" display_stop="154888061" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154114634" stop="154116335" display_start="154114634" display_stop="154116335" Strand="+" />
          </Location>
          <OMIM>305423</OMIM>
        </Gene>
        <Gene Symbol="F8A2" FullName="coagulation factor VIII associated 2" GeneID="474383" HGNC_ID="HGNC:31849" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155382095" stop="155383801" display_start="155382095" display_stop="155383801" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154611763" stop="154612878" display_start="154611763" display_stop="154612878" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="F8A3" FullName="coagulation factor VIII associated 3" GeneID="474384" HGNC_ID="HGNC:31850" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155456914" stop="155458620" display_start="155456914" display_stop="155458620" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154687145" stop="154688260" display_start="154687145" display_stop="154688260" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="FAM3A" FullName="FAM3 metabolism regulating signaling molecule A" GeneID="60343" HGNC_ID="HGNC:13749" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154506171" stop="154516232" display_start="154506171" display_stop="154516232" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153733322" stop="153744565" display_start="153733322" display_stop="153744565" Strand="-" />
          </Location>
          <OMIM>300492</OMIM>
        </Gene>
        <Gene Symbol="FAM50A" FullName="family with sequence similarity 50 member A" GeneID="9130" HGNC_ID="HGNC:18786" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154444141" stop="154450654" display_start="154444141" display_stop="154450654" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153672472" stop="153679001" display_start="153672472" display_stop="153679001" Strand="+" />
          </Location>
          <OMIM>300453</OMIM>
        </Gene>
        <Gene Symbol="FLNA" FullName="filamin A" GeneID="2316" HGNC_ID="HGNC:3754" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154348531" stop="154374634" display_start="154348531" display_stop="154374634" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153576899" stop="153603005" display_start="153576899" display_stop="153603005" Strand="-" />
          </Location>
          <OMIM>300017</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="FUNDC2" FullName="FUN14 domain containing 2" GeneID="65991" HGNC_ID="HGNC:24925" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155026844" stop="155060304" display_start="155026844" display_stop="155060304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154255063" stop="154285190" display_start="154255063" display_stop="154285190" Strand="+" />
          </Location>
          <OMIM>301042</OMIM>
        </Gene>
        <Gene Symbol="G6PD" FullName="glucose-6-phosphate dehydrogenase" GeneID="2539" HGNC_ID="HGNC:4057" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154531390" stop="154547569" display_start="154531390" display_stop="154547569" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153759605" stop="153775786" display_start="153759605" display_stop="153775786" Strand="-" />
          </Location>
          <OMIM>305900</OMIM>
        </Gene>
        <Gene Symbol="GAB3" FullName="GRB2 associated binding protein 3" GeneID="139716" HGNC_ID="HGNC:17515" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154675249" stop="154751566" display_start="154675249" display_stop="154751566" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153903525" stop="153979347" display_start="153903525" display_stop="153979347" Strand="-" />
          </Location>
          <OMIM>300482</OMIM>
        </Gene>
        <Gene Symbol="GDI1" FullName="GDP dissociation inhibitor 1" GeneID="2664" HGNC_ID="HGNC:4226" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154437154" stop="154443467" display_start="154437154" display_stop="154443467" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153665258" stop="153671813" display_start="153665258" display_stop="153671813" Strand="+" />
          </Location>
          <OMIM>300104</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDI1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDI1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="H2AB1" FullName="H2A.B variant histone 1" GeneID="474382" HGNC_ID="HGNC:22516" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154884972" stop="154885558" display_start="154884972" display_stop="154885558" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154113316" stop="154113832" display_start="154113316" display_stop="154113832" Strand="+" />
          </Location>
          <OMIM>301037</OMIM>
        </Gene>
        <Gene Symbol="H2AB2" FullName="H2A.B variant histone 2" GeneID="474381" HGNC_ID="HGNC:18298" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155380709" stop="155381299" display_start="155380709" display_stop="155381299" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154610435" stop="154610782" display_start="154610435" display_stop="154610782" Strand="+" />
          </Location>
          <OMIM>301038</OMIM>
        </Gene>
        <Gene Symbol="H2AB3" FullName="H2A.B variant histone 3" GeneID="83740" HGNC_ID="HGNC:14455" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155459415" stop="155460005" display_start="155459415" display_stop="155460005" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154689079" stop="154689595" display_start="154689079" display_stop="154689595" Strand="-" />
          </Location>
          <OMIM>300445</OMIM>
        </Gene>
        <Gene Symbol="HAUS7" FullName="HAUS augmin like complex subunit 7" GeneID="55559" HGNC_ID="HGNC:32979" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153447668" stop="153495465" display_start="153447668" display_stop="153495465" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152713122" stop="152760982" display_start="152713122" display_stop="152760982" Strand="-" />
          </Location>
          <OMIM>300540</OMIM>
        </Gene>
        <Gene Symbol="HCFC1" FullName="host cell factor C1" GeneID="3054" HGNC_ID="HGNC:4839" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153947557" stop="153971818" display_start="153947557" display_stop="153971818" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153213007" stop="153236818" display_start="153213007" display_stop="153236818" Strand="-" />
          </Location>
          <OMIM>300019</OMIM>
        </Gene>
        <Gene Symbol="IDH3G" FullName="isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" GeneID="3421" HGNC_ID="HGNC:5386" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153785768" stop="153794375" display_start="153785768" display_stop="153794375" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153051220" stop="153059977" display_start="153051220" display_stop="153059977" Strand="-" />
          </Location>
          <OMIM>300089</OMIM>
        </Gene>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="IRAK1" FullName="interleukin 1 receptor associated kinase 1" GeneID="3654" HGNC_ID="HGNC:6112" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154010507" stop="154019902" display_start="154010507" display_stop="154019902" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153275956" stop="153285341" display_start="153275956" display_stop="153285341" Strand="-" />
          </Location>
          <OMIM>300283</OMIM>
        </Gene>
        <Gene Symbol="L1CAM" FullName="L1 cell adhesion molecule" GeneID="3897" HGNC_ID="HGNC:6470" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153861514" stop="153886173" display_start="153861514" display_stop="153886173" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153126970" stop="153141398" display_start="153126970" display_stop="153141398" Strand="-" />
          </Location>
          <OMIM>308840</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=L1CAM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=L1CAM">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LAGE3" FullName="L antigen family member 3" GeneID="8270" HGNC_ID="HGNC:26058" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154477775" stop="154479281" display_start="154477775" display_stop="154479281" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153705240" stop="153707595" display_start="153705240" display_stop="153707595" Strand="-" />
          </Location>
          <OMIM>300060</OMIM>
        </Gene>
        <Gene Symbol="MAGEA1" FullName="MAGE family member A1" GeneID="4100" HGNC_ID="HGNC:6796" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153179284" stop="153183880" display_start="153179284" display_stop="153183880" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152481521" stop="152486115" display_start="152481521" display_stop="152486115" Strand="-" />
          </Location>
          <OMIM>300016</OMIM>
        </Gene>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="MPP1" FullName="MAGUK p55 scaffold protein 1" GeneID="4354" HGNC_ID="HGNC:7219" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154778684" stop="154805485" display_start="154778684" display_stop="154805485" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154006958" stop="154033801" display_start="154006958" display_stop="154033801" Strand="-" />
          </Location>
          <OMIM>305360</OMIM>
        </Gene>
        <Gene Symbol="MTCP1" FullName="mature T cell proliferation 1" GeneID="4515" HGNC_ID="HGNC:7423" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155064034" stop="155071136" display_start="155064034" display_stop="155071136" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154292308" stop="154299546" display_start="154292308" display_stop="154299546" Strand="-" />
          </Location>
          <OMIM>300116</OMIM>
        </Gene>
        <Gene Symbol="NAA10" FullName="N-alpha-acetyltransferase 10, NatA catalytic subunit" GeneID="8260" HGNC_ID="HGNC:18704" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153929225" stop="153935037" display_start="153929225" display_stop="153935037" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153195279" stop="153200606" display_start="153195279" display_stop="153200606" Strand="-" />
          </Location>
          <OMIM>300013</OMIM>
          <Haploinsufficiency last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NAA10">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-08-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NAA10">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="NSDHL" FullName="NAD(P) dependent steroid dehydrogenase-like" GeneID="50814" HGNC_ID="HGNC:13398" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="152831063" stop="152869729" display_start="152831063" display_stop="152869729" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791818.1" start="446253" stop="484919" display_start="446253" display_stop="484919" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="151999510" stop="152037906" display_start="151999510" display_stop="152037906" Strand="+" />
          </Location>
          <OMIM>300275</OMIM>
          <Haploinsufficiency last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSDHL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-09-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSDHL">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="OPN1LW" FullName="opsin 1, long wave sensitive" GeneID="5956" HGNC_ID="HGNC:9936" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154144243" stop="154159032" display_start="154144243" display_stop="154159032" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153409724" stop="153424506" display_start="153409724" display_stop="153424506" Strand="+" />
          </Location>
          <OMIM>300822</OMIM>
        </Gene>
        <Gene Symbol="OPN1MW" FullName="opsin 1, medium wave sensitive" GeneID="2652" HGNC_ID="HGNC:4206" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154182596" stop="154196861" display_start="154182596" display_stop="154196861" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153448084" stop="153462351" display_start="153448084" display_stop="153462351" Strand="+" />
          </Location>
          <OMIM>300821</OMIM>
        </Gene>
        <Gene Symbol="OPN1MW2" FullName="opsin 1, medium wave sensitive 2" GeneID="728458" HGNC_ID="HGNC:26952" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154219756" stop="154233286" display_start="154219756" display_stop="154233286" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153485202" stop="153498754" display_start="153485202" display_stop="153498754" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PDZD4" FullName="PDZ domain containing 4" GeneID="57595" HGNC_ID="HGNC:21167" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153802166" stop="153830544" display_start="153802166" display_stop="153830544" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153067622" stop="153096002" display_start="153067622" display_stop="153096002" Strand="-" />
          </Location>
          <OMIM>300634</OMIM>
        </Gene>
        <Gene Symbol="PLXNA3" FullName="plexin A3" GeneID="55558" HGNC_ID="HGNC:9101" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154458281" stop="154477779" display_start="154458281" display_stop="154477779" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153686622" stop="153701984" display_start="153686622" display_stop="153701984" Strand="+" />
          </Location>
          <OMIM>300022</OMIM>
        </Gene>
        <Gene Symbol="PLXNB3" FullName="plexin B3" GeneID="5365" HGNC_ID="HGNC:9105" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153764249" stop="153779341" display_start="153764249" display_stop="153779341" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153029650" stop="153044800" display_start="153029650" display_stop="153044800" Strand="+" />
          </Location>
          <OMIM>300214</OMIM>
        </Gene>
        <Gene Symbol="PNCK" FullName="pregnancy up-regulated nonubiquitous CaM kinase" GeneID="139728" HGNC_ID="HGNC:13415" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153669733" stop="153687771" display_start="153669733" display_stop="153687771" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152935187" stop="152939815" display_start="152935187" display_stop="152939815" Strand="-" />
          </Location>
          <OMIM>300680</OMIM>
        </Gene>
        <Gene Symbol="PNMA3" FullName="PNMA family member 3" GeneID="29944" HGNC_ID="HGNC:18742" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153056470" stop="153060462" display_start="153056470" display_stop="153060462" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152224765" stop="152228826" display_start="152224765" display_stop="152228826" Strand="+" />
          </Location>
          <OMIM>300675</OMIM>
        </Gene>
        <Gene Symbol="PNMA5" FullName="PNMA family member 5" GeneID="114824" HGNC_ID="HGNC:18743" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="152988824" stop="152994116" display_start="152988824" display_stop="152994116" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791818.1" start="604014" stop="609306" display_start="604014" display_stop="609306" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152157367" stop="152162670" display_start="152157367" display_stop="152162670" Strand="-" />
          </Location>
          <OMIM>300916</OMIM>
        </Gene>
        <Gene Symbol="PNMA6A" FullName="PNMA family member 6A" GeneID="84968" HGNC_ID="HGNC:28248" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153072454" stop="153075019" display_start="153072454" display_stop="153075019" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152338300" stop="152340106" display_start="152338300" display_stop="152340106" Strand="+" />
          </Location>
          <OMIM>300917</OMIM>
        </Gene>
        <Gene Symbol="PNMA6E" FullName="PNMA family member 6E" GeneID="649238" HGNC_ID="HGNC:50767" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153395639" stop="153414004" display_start="153395639" display_stop="153414004" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152662364" stop="152666148" display_start="152662364" display_stop="152666148" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NW_003871103.2" start="870031" stop="873815" display_start="870031" display_stop="873815" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="RAB39B" FullName="RAB39B, member RAS oncogene family" GeneID="116442" HGNC_ID="HGNC:16499" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155258235" stop="155264491" display_start="155258235" display_stop="155264491" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154487525" stop="154493851" display_start="154487525" display_stop="154493851" Strand="-" />
          </Location>
          <OMIM>300774</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAB39B">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAB39B">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="RENBP" FullName="renin binding protein" GeneID="5973" HGNC_ID="HGNC:9959" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153935269" stop="153944643" display_start="153935269" display_stop="153944643" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153200721" stop="153210231" display_start="153200721" display_stop="153210231" Strand="-" />
          </Location>
          <OMIM>312420</OMIM>
        </Gene>
        <Gene Symbol="RPL10" FullName="ribosomal protein L10" GeneID="6134" HGNC_ID="HGNC:10298" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154398065" stop="154402339" display_start="154398065" display_stop="154402339" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153626570" stop="153630679" display_start="153626570" display_stop="153630679" Strand="+" />
          </Location>
          <OMIM>312173</OMIM>
          <Haploinsufficiency last_evaluated="2018-10-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPL10">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-10-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPL10">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SLC10A3" FullName="solute carrier family 10 member 3" GeneID="8273" HGNC_ID="HGNC:22979" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154487311" stop="154490629" display_start="154487311" display_stop="154490629" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153715649" stop="153719001" display_start="153715649" display_stop="153719001" Strand="-" />
          </Location>
          <OMIM>312090</OMIM>
        </Gene>
        <Gene Symbol="SLC6A8" FullName="solute carrier family 6 member 8" GeneID="6535" HGNC_ID="HGNC:11055" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153687926" stop="153696593" display_start="153687926" display_stop="153696593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152953751" stop="152962047" display_start="152953751" display_stop="152962047" Strand="+" />
          </Location>
          <OMIM>300036</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SMIM9" FullName="small integral membrane protein 9" GeneID="100132963" HGNC_ID="HGNC:41915" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154823348" stop="154834662" display_start="154823348" display_stop="154834662" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154051622" stop="154062936" display_start="154051622" display_stop="154062936" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="SRPK3" FullName="SRSF protein kinase 3" GeneID="26576" HGNC_ID="HGNC:11402" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153781041" stop="153785730" display_start="153781041" display_stop="153785730" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153046455" stop="153051186" display_start="153046455" display_stop="153051186" Strand="+" />
          </Location>
          <OMIM>301002</OMIM>
        </Gene>
        <Gene Symbol="SSR4" FullName="signal sequence receptor subunit 4" GeneID="6748" HGNC_ID="HGNC:11326" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153794159" stop="153798512" display_start="153794159" display_stop="153798512" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153059629" stop="153063966" display_start="153059629" display_stop="153063966" Strand="+" />
          </Location>
          <OMIM>300090</OMIM>
        </Gene>
        <Gene Symbol="TAFAZZIN" FullName="tafazzin, phospholipid-lysophospholipid transacylase" GeneID="6901" HGNC_ID="HGNC:11577" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154411539" stop="154421726" display_start="154411539" display_stop="154421726" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153639876" stop="153650064" display_start="153639876" display_stop="153650064" Strand="+" />
          </Location>
          <OMIM>300394</OMIM>
        </Gene>
        <Gene Symbol="TEX28" FullName="testis expressed 28" GeneID="1527" HGNC_ID="HGNC:2563" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154271265" stop="154295211" display_start="154271265" display_stop="154295211" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153498929" stop="153523563" display_start="153498929" display_stop="153523563" Strand="-" />
          </Location>
          <OMIM>300092</OMIM>
        </Gene>
        <Gene Symbol="TKTL1" FullName="transketolase like 1" GeneID="8277" HGNC_ID="HGNC:11835" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154295795" stop="154330350" display_start="154295795" display_stop="154330350" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153524026" stop="153558712" display_start="153524026" display_stop="153558712" Strand="+" />
          </Location>
          <OMIM>300044</OMIM>
        </Gene>
        <Gene Symbol="TMEM187" FullName="transmembrane protein 187" GeneID="8269" HGNC_ID="HGNC:13705" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153972754" stop="153983194" display_start="153972754" display_stop="153983194" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153237990" stop="153248645" display_start="153237990" display_stop="153248645" Strand="+" />
          </Location>
          <OMIM>300059</OMIM>
        </Gene>
        <Gene Symbol="TMLHE" FullName="trimethyllysine hydroxylase, epsilon" GeneID="55217" HGNC_ID="HGNC:18308" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155489011" stop="155612952" display_start="155489011" display_stop="155612952" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154718671" stop="154842621" display_start="154718671" display_stop="154842621" Strand="-" />
          </Location>
          <OMIM>300777</OMIM>
          <Haploinsufficiency last_evaluated="2013-08-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TMLHE">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-08-01" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TMLHE">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="TREX2" FullName="three prime repair exonuclease 2" GeneID="11219" HGNC_ID="HGNC:12270" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153444473" stop="153446056" display_start="153444473" display_stop="153446056" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152710177" stop="152711944" display_start="152710177" display_stop="152711944" Strand="-" />
          </Location>
          <OMIM>300370</OMIM>
        </Gene>
        <Gene Symbol="UBL4A" FullName="ubiquitin like 4A" GeneID="8266" HGNC_ID="HGNC:12505" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154483717" stop="154486615" display_start="154483717" display_stop="154486615" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153712055" stop="153714931" display_start="153712055" display_stop="153714931" Strand="-" />
          </Location>
          <OMIM>312070</OMIM>
        </Gene>
        <Gene Symbol="VBP1" FullName="VHL binding protein 1" GeneID="7411" HGNC_ID="HGNC:12662" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="155197007" stop="155239841" display_start="155197007" display_stop="155239841" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="154444700" stop="154468097" display_start="154444700" display_stop="154468097" Strand="+" />
          </Location>
          <OMIM>300133</OMIM>
        </Gene>
        <Gene Symbol="ZFP92" FullName="ZFP92 zinc finger protein" GeneID="139735" HGNC_ID="HGNC:12865" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153411472" stop="153426481" display_start="153411472" display_stop="153426481" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152683780" stop="152687085" display_start="152683780" display_stop="152687085" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="ZNF185" FullName="zinc finger protein 185 with LIM domain" GeneID="7739" HGNC_ID="HGNC:12976" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="152898067" stop="152973481" display_start="152898067" display_stop="152973481" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NW_025791818.1" start="513257" stop="588671" display_start="513257" display_stop="588671" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152082985" stop="152142024" display_start="152082985" display_stop="152142024" Strand="+" />
          </Location>
          <OMIM>300381</OMIM>
        </Gene>
        <Gene Symbol="ZNF275" FullName="zinc finger protein 275" GeneID="10838" HGNC_ID="HGNC:13069" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153334153" stop="153352926" display_start="153334153" display_stop="153352926" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152599612" stop="152618383" display_start="152599612" display_stop="152618383" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_152014869)_(155171615_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="152014869" innerStop="155171615" display_start="152014869" display_stop="155171615" variantLength="3156747" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_152014869)_(155171615_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_152014869)_(155171615_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND Spastic paraplegia" Accession="RCV003109219" Version="4">
        <ClassifiedConditionList TraitSetID="20865">
          <ClassifiedCondition DB="MedGen" ID="C0037772">Spastic paraplegia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND multiple conditions" Accession="RCV003109218" Version="4">
        <ClassifiedConditionList TraitSetID="53144">
          <ClassifiedCondition DB="MedGen" ID="C0265293">Frontometaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848213">Heterotopia, periventricular, X-linked dominant</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0025237">Melnick-Needles syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1844696">Oto-palato-digital syndrome, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND Creatine transporter deficiency" Accession="RCV003119103" Version="3">
        <ClassifiedConditionList TraitSetID="3187">
          <ClassifiedCondition DB="MedGen" ID="C1845862">Creatine transporter deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND X-linked Emery-Dreifuss muscular dystrophy" Accession="RCV003119102" Version="5">
        <ClassifiedConditionList TraitSetID="6541">
          <ClassifiedCondition DB="MedGen" ID="C0751337">X-linked Emery-Dreifuss muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND 3-Methylglutaconic aciduria type 2" Accession="RCV003119101" Version="4">
        <ClassifiedConditionList TraitSetID="3071">
          <ClassifiedCondition DB="MedGen" ID="C0574083">3-Methylglutaconic aciduria type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000023.10:g.(?_152014869)_(155171615_?)del AND Adrenoleukodystrophy" Accession="RCV003119100" Version="3">
        <ClassifiedConditionList TraitSetID="3100">
          <ClassifiedCondition DB="MedGen" ID="C0162309">Adrenoleukodystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-17" NumberOfSubmissions="6" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10480214</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11748843</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11968085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16427346</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16601897</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16684786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19396829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19846429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20730588</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22281021</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22382802</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23409742</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23660394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24365856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24962355</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26471271</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29334594</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9384614</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6541" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked Emery-Dreifuss muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0010680" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, tardive Emery-Dreifuss type, with contractures</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2102" />
                <XRef ID="2102" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <XRef ID="261" DB="Orphanet" />
              <XRef ID="98863" DB="Orphanet" />
              <XRef ID="C0751337" DB="MedGen" />
              <XRef ID="MONDO:0010680" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3100" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="139" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ADDISON DISEASE AND CEREBRAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRONZE SCHILDER DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MELANODERMIC LEUKODYSTROPHY</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SIEMERLING-CREUTZFELDT DISEASE</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Adrenoleukodystrophy</ElementValue>
                <XRef ID="Adrenoleukodystrophy/242" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018544" DB="MONDO" />
                <XRef ID="65389002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">Adrenoleukodystrophy, ID</ElementValue>
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">X-ALD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ALD</ElementValue>
                <XRef Type="MIM" ID="300100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000503092" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500892" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508448" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522163" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330513" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521375" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559496" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500811" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503088" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000318975" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000070507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522267" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512569" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519128" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561876" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522268" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5758" />
                <XRef ID="5758" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked adrenoleukodystrophy (X-ALD) affects the nervous system white matter and the adrenal cortex. Three main phenotypes are seen in affected males: The childhood cerebral form manifests most commonly between ages four and eight years. It initially resembles attention-deficit disorder or hyperactivity; progressive impairment of cognition, behavior, vision, hearing, and motor function follow the initial symptoms and often lead to total disability within six months to two years. Most individuals have impaired adrenocortical function at the time that neurologic disturbances are first noted. Adrenomyeloneuropathy (AMN) manifests most commonly in an individual in his twenties or middle age as progressive stiffness and weakness of the legs, sphincter disturbances, sexual dysfunction, and often, impaired adrenocortical function; all symptoms are progressive over decades. "Addison disease only" presents with primary adrenocortical insufficiency between age two years and adulthood and most commonly by age 7.5 years, without evidence of neurologic abnormality; however, some degree of neurologic disability (most commonly AMN) usually develops by middle age. More than 20% of female carriers develop mild-to-moderate spastic paraparesis in middle age or later. Adrenal function is usually normal.</Attribute>
                <XRef ID="NBK1315" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301491</ID>
                <ID Source="BookShelf">NBK1315</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22071894</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2021">
                <URL>https://publications.aap.org/pediatrics/article/148/3/e2021053126/181065/Leukodystrophies-in-Children-Diagnosis-Care-and</URL>
                <CitationText>Leukodystrophies in Children: Diagnosis, Care, and Treatment, Pediatrics (2021) 148 (3): e2021053126.</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated lysophosphatidylcholines, X-Linked Adrenoleukodystrophy (X-ALD), 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2023">
                <URL>https://www.acmg.net/PDFLibrary/X-ALD-Algorithm.pdf</URL>
                <CitationText>ACMG Algorithm, X-ALD: Elevated lysophosphatidylcholines C24:0, C26:0, 2023</CitationText>
              </Citation>
              <XRef ID="43" DB="Orphanet" />
              <XRef ID="C0162309" DB="MedGen" />
              <XRef ID="MONDO:0018544" DB="MONDO" />
              <XRef Type="MIM" ID="300100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="53144" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3340" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Andre syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPD 2 syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cranio-oro-digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Faciopalatoosseous syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Otopalatodigital Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPD II SYNDROME</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oto-palato-digital syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oto-palato-digital syndrome, type II</ElementValue>
                <XRef ID="Oto-palato-digital+syndrome+type+2/5496" DB="Genetic Alliance" />
                <XRef ID="42432003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OPD2</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPO</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5802" />
                <XRef ID="5802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="669" DB="Orphanet" />
              <XRef ID="90652" DB="Orphanet" />
              <XRef ID="C1844696" DB="MedGen" />
              <XRef ID="MONDO:0010571" DB="MONDO" />
              <XRef Type="MIM" ID="304120" DB="OMIM" />
            </Trait>
            <Trait ID="2842" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Melnick-Needles osteodysplasty</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteodysplasty of Melnick and Needles</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melnick-Needles syndrome</ElementValue>
                <XRef ID="Melnick-Needles+syndrome/4587" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010650" DB="MONDO" />
                <XRef ID="13449007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MNS</ElementValue>
                <XRef Type="MIM" ID="309350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7011" />
                <XRef ID="7011" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="2484" DB="Orphanet" />
              <XRef ID="C0025237" DB="MedGen" />
              <XRef ID="MONDO:0010650" DB="MONDO" />
              <XRef Type="MIM" ID="309350" DB="OMIM" />
            </Trait>
            <Trait ID="1645" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Heterotopia familial nodular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nodular heterotopia bilateral periventricular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 4</ElementValue>
                <XRef Type="MIM" ID="300537" DB="OMIM" />
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HETEROTOPIA, PERIVENTRICULAR, 1</ElementValue>
                <XRef Type="Allelic variant" ID="300017.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked periventricular heterotopia</ElementValue>
                <XRef ID="X-linked+periventricular+heterotopia/7556" DB="Genetic Alliance" />
                <XRef ID="448227009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Heterotopia, periventricular, X-linked dominant</ElementValue>
                <XRef ID="MONDO:0010233" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PVNH4</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
                <XRef Type="MIM" ID="300537" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NHBP</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BPNH</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PVNH1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">FLNA deficiency is associated with a phenotypic spectrum that includes FLNA-related periventricular nodular heterotopia (Huttenlocher syndrome), congenital heart disease (patent ductus arteriosus, atrial and ventricular septal defects), valvular dystrophy, dilation and rupture of the thoracic aortic, pulmonary disease (pulmonary hypertension, alveolar hypoplasia, emphysema, asthma, chronic bronchitis), gastrointestinal dysmotility and obstruction, joint hypermobility, and macrothrombocytopenia.</Attribute>
                <XRef ID="NBK1213" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Periventricular Nodular Heterotopia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7371" />
                <XRef ID="7371" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301392</ID>
                <ID Source="BookShelf">NBK1213</ID>
              </Citation>
              <XRef ID="2149" DB="Orphanet" />
              <XRef ID="82004" DB="Orphanet" />
              <XRef ID="C1848213" DB="MedGen" />
              <XRef ID="MONDO:0010233" DB="MONDO" />
              <XRef Type="MIM" ID="300049" DB="OMIM" />
            </Trait>
            <Trait ID="43500" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Frontometaphyseal dysplasia</ElementValue>
                <XRef ID="Frontometaphyseal+Dysplasia/2937" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015942" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
                <XRef ID="62803002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FMD</ElementValue>
                <XRef Type="MIM" ID="305620" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FMD1</ElementValue>
                <XRef ID="GTR000519546" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="826" />
                <XRef ID="826" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1826" DB="Orphanet" />
              <XRef ID="C0265293" DB="MedGen" />
              <XRef ID="MONDO:0015942" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="20865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32966" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spastic paraplegia</ElementValue>
                <XRef ID="10DG0885" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                <XRef ID="HP:0001258" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0037772" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001258" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007062" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007124" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0007216" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1686" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Creatine transporter deficiency</ElementValue>
                <XRef ID="MONDO:0010305" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency, X-linked</ElementValue>
                <XRef ID="Creatine+Deficiency%2C+X-Linked/2001" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked with seizures, short stature and midface hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked, with creatine transport deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC6A8-Related Creatine Transporter Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CREATINE TRANSPORTER DEFECT</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1608" />
                <XRef ID="1608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="52503" DB="Orphanet" />
              <XRef ID="C1845862" DB="MedGen" />
              <XRef ID="MONDO:0010305" DB="MONDO" />
              <XRef Type="MIM" ID="300352" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3071" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="487" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Barth syndrome</ElementValue>
                <XRef ID="MONDO:0010543" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconicaciduria type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioskeletal myopathy with neutropenia and abnormal mitochondria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Methylglutaconic aciduria type 2</ElementValue>
                <XRef ID="Barth+Syndrome/744" DB="Genetic Alliance" />
                <XRef ID="297231002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGCA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BTHS</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial gestalt (most evident in infancy); not all features may be present in a given affected male. Cardiomyopathy, which is almost always present before age five years, is typically dilated cardiomyopathy with or without endocardial fibroelastosis or left ventricular noncompaction; hypertrophic cardiomyopathy can also occur. Heart failure is a significant cause of morbidity and mortality; risk of arrhythmia and sudden death is increased. Neutropenia is most often associated with mouth ulcers, pneumonia, and sepsis. The nonprogressive myopathy predominantly affects the proximal muscles, and results in early motor delays. Prepubertal growth delay is followed by a postpubertal growth spurt with remarkable "catch-up" growth. Heterozygous females who have a normal karyotype are asymptomatic and have normal biochemical studies.</Attribute>
                <XRef ID="NBK247162" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5890" />
                <XRef ID="5890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299040</ID>
                <ID Source="BookShelf">NBK247162</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="111" DB="Orphanet" />
              <XRef ID="C0574083" DB="MedGen" />
              <XRef ID="MONDO:0010543" DB="MONDO" />
              <XRef Type="MIM" ID="302060" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7070916" SubmissionDate="2023-02-03" DateLastUpdated="2023-02-13" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000033.3_Deletion (Entire Coding Sequence)|MedGen:C0162309" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790062" DateUpdated="2023-02-13" DateCreated="2023-02-13" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11748843</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the ABCD1 gene has been identified. Loss-of-function variants in ABCD1 are known to be pathogenic (PMID: 11748843). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with ABCD1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ABCD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0162309" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7071142" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000117.2_Deletion (Entire Coding Sequence)|MedGen:C0751337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790643" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24365856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9384614</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10480214</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the EMD gene has been identified. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individuals with EmeryDreifuss muscular dystrophy (EDMD) (PMID: 9384614, 10480214). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751337" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7071137" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000116.4_Deletion (Entire Coding Sequence)|MedGen:C0574083" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003790638" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16427346</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22382802</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23409742</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19396829</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the TAZ gene has been identified. Loss-of-function variants in TAZ are known to be pathogenic (PMID: 16427346, 22382802, 23409742). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with Barth syndrome (PMID: 19396829). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TAFAZZIN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0574083" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7071834" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_000425.4_Deletion (Entire Coding Sequence)|MedGen:C0037772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003793205" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19846429</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11968085</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the L1CAM gene has been identified. Loss-of-function variants in L1CAM are known to be pathogenic (PMID: 19846429). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with X-linked hydrocephalus (PMID: 11968085). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="L1CAM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0037772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7073007" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_001456.3_Deletion (Entire Coding Sequence)|MedGen:C1844696;C1848213;C0265293;C0025237" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003793582" DateUpdated="2023-11-11" DateCreated="2023-02-13" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16684786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20730588</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26471271</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29334594</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the FLNA gene has been identified. Loss-of-function variants in FLNA are known to be pathogenic (PMID: 16684786, 20730588, 26471271). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with periventricular nodular heterotopia (PMID: 29334594). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1844696" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848213" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265293" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025237" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7074277" SubmissionDate="2023-02-03" DateLastUpdated="2023-02-13" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_005629.3_Deletion (Entire Coding Sequence)|MedGen:C1845862" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003794848" DateUpdated="2023-02-13" DateCreated="2023-02-13" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22281021</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16601897</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23660394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24962355</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the SLC6A8 gene has been identified. Loss-of-function variants in SLC6A8 are known to be pathogenic (PMID: 22281021). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with clinical features of creatinine transporter deficiency (PMID: 16601897, 23660394, 24962355). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_152014869)_(155171615_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845862" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7073007" TraitType="Disease" MappingType="XRef" MappingValue="C1848213" MappingRef="MedGen">
        <MedGen CUI="C1848213" Name="Heterotopia, periventricular, X-linked dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071834" TraitType="Disease" MappingType="XRef" MappingValue="C0037772" MappingRef="MedGen">
        <MedGen CUI="C0037772" Name="Spastic paraplegia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071137" TraitType="Disease" MappingType="XRef" MappingValue="C0574083" MappingRef="MedGen">
        <MedGen CUI="C0574083" Name="3-Methylglutaconic aciduria type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073007" TraitType="Disease" MappingType="XRef" MappingValue="C0265293" MappingRef="MedGen">
        <MedGen CUI="C0265293" Name="Frontometaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073007" TraitType="Disease" MappingType="XRef" MappingValue="C0025237" MappingRef="MedGen">
        <MedGen CUI="C0025237" Name="Melnick-Needles syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7074277" TraitType="Disease" MappingType="XRef" MappingValue="C1845862" MappingRef="MedGen">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7071142" TraitType="Disease" MappingType="XRef" MappingValue="C0751337" MappingRef="MedGen">
        <MedGen CUI="C0751337" Name="X-linked Emery-Dreifuss muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073007" TraitType="Disease" MappingType="XRef" MappingValue="C1844696" MappingRef="MedGen">
        <MedGen CUI="C1844696" Name="Oto-palato-digital syndrome, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7070916" TraitType="Disease" MappingType="XRef" MappingValue="C0162309" MappingRef="MedGen">
        <MedGen CUI="C0162309" Name="Adrenoleukodystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

